robert henric

robert henric

Followers 12
Following 19
According to the new market research report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) – Global Forecast ” published by MarketsandMarkets™The Synthetic Stem Cells Market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period.Major Market Growth Drivers:Ethical Concerns Regarding Embryonic Stem CellsRisk of Tumor Formation and Immune Rejection of Natural Stem CellsPotential Application in Major IndicationsIncreasing Stem Cell Research FundingReport Objectives:To define, describe, and forecast the artificial stem cells market based on application and regionTo provide detailed information about factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)To analyze micromarkets with respect to individual growth trends, prospects, and contribution to the overall marketTo analyze market opportunities for stakeholdersTo forecast the size of the market segments in North America, Europe, Asia Pacific, and the Rest of the World (RoW)Browse 4 market data Tables and 17 Figures spread through 55 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435The cardiovascular diseases segment is expected to command the largest share of the overall synthetic stem cells market during the forecast period.By application, is estimated to be dominated by the cardiovascular diseases segment in 2023.This is attributed to the fact that the synthetic stem cells have been firstly developed for cardiac tissue and are tested in mice models.After the successful pre-clinical testing of cardiac synthetic stem cells, these cells will enter the clinical phase of development and are expected to hit the market by 2023.North America to lead the synthetic stem cells market with accelerated R activities in stem cell therapy research.North America is estimated to account for the largest share of the market in 2023.North America is the pioneer of synthetic stem cell technology.Also, North America leads in the R of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018.This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).   
2
According to the new market research report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bioprocessing.Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays.The Cell Harvesting Market is expected to grow at a CAGR of 8.7% during the forecast period to reach USD 324.5 Million.Growth Boosting Factors:Rising Investments in Regenerative Medicine and Cell-Based ResearchGrowth of the Biotechnology and Biopharmaceutical IndustryIncreasing Incidence of Chronic and Infectious DiseasesGrowth Opportunities in Emerging EconomiesBrowse 67 market data Tables and 27 Figures spread through 101 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544Market Segmentation in Depth:On the basis of type, the market is segmented into manual and automated cell harvesters.In 2017, the manual cell harvesters segment accounted for the largest share of this market.The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.In the end user, the cell harvesting market is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users.The biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market.The high share of this segment can be attributed to the high prevalence of chronic diseases.
1
According to the new market research report “Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA) – Global Forecast” published by MarketsandMarkets™.The Global Thyroid Function Test Market is projected to reach USD 1.68 Billion, at a CAGR of 5.9% during the forecast period.Major Market Growth Drivers:Increasing Incidence of Thyroid DisordersIncreasing Awareness About Thyroid DisordersIncreasing Prevalence of Lifestyle Diseases and Rising Geriatric PopulationIncreasing Consumption of Alcohol and TobaccoGrowth Opportunities in Emerging Asia Pacific CountriesObjectives of the Study:To define, describe, segment, and forecast the global market by type, end user, and regionTo provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)To analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall marketTo analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leadersBrowse 65 tables and 31 figures spread through 120 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=85085049Market Segmentation in Depth:On the basis of type, the market is segmented into TSH tests, T4 tests, T3 tests, and other tests.The TSH tests segment is estimated to account for the largest share of the thyroid function tests market.The large share rate of this segment can be attributed to the fact that TSH tests are initially prescribed by physicians to majority of patients (for the assessment of thyroid gland functioning) showing symptoms of thyroid disorders.Based on end users, the global thyroid function tests market is broadly segmented into hospitals, diagnostic laboratories, research laboratories and institutes, and other end users.The hospitals segment is estimated to account for the largest share of the global thyroid function test market.The large share of the segment can be attributed to the growing patient population & the subsequent increase in clinical tests performed in hospitals and growing number of public healthcare awareness campaigns organized by hospitals.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=85085049Geographically, the North American market is expected to account for the largest share of the global thyroid function test market due to the presence of an advanced healthcare infrastructure in North American countries such as the US and Canada.However, the Asia Pacific market is expected to grow at the highest CAGR in the forecast period.
1
According to the new market research report “Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast” published by MarketsandMarkets™.The Global Embolic Protection Devices Market is projected to reach USD 604.9 Million by 2023 at a CAGR of 8.3% during the forecast period.Major Market Growth Drivers:Rising Incidence of Cardiovascular & Neurovascular DiseasesFunding and Investments for R on Embolic Protection DevicesTechnological AdvancementsRising Demand for Minimally Invasive ProceduresGrowth Opportunities in Emerging MarketsBrowse 127 tables and 28 figures spread through 172 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803Objectives of the Study;To define, describe, and forecast the embolic protection devices market by product type & material, application, indication, end user, and regionTo provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall marketThe neurovascular segment is expected to grow at the highest CAGR during the forecast period.On the basis of application, categorized into cardiovascular, neurovascular, and peripheral vascular diseases.The neurovascular segment is expected to grow at the highest CAGR during the forecast period.The favorable medical reimbursement scenarios for neurovascular procedures in developed countries, increasing awareness about the clinical efficacy of embolic protection devices among neurosurgeons, and the rising adoption of these systems across developing countries (such as China and India) are expected to drive the growth of this application segment during the forecast period.The percutaneous coronary intervention segment accounted for the largest market share.On the basis of indication, categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications.In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market.The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803North America dominated the embolic protection devices market.The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of a large number of medical device product manufacturers are driving the growth of the market in North America.
2
360Quadrants has released a quadrant on best project management software to help businesses make quicker and more informed decisions.Ranking quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the project management industry.Competitive Leadership Mapping Terminology:The competitive leadership mapping showcased provides information for Project Management Solution.The evaluation criteria considered under product offerings include the breadth of offering, delivery (based on industries that the vendors cater to, deployment models, and subscriptions), features/functionality, delivery, product quality and reliability, and product differentiation.The evaluation criteria considered under business strategy include geographic footprint (on the basis of geographic presence), channel strategy and fit, vision alignment, and effectiveness of growth (on the basis of innovations, partnerships, collaborations, and acquisitions).Read a Press Release on “Project Management Software”:https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-project-management-software-providersWhat are the major applications of Project Management Software?In Automobile Industry-Project Management Software Solutions in the Automotive Industry help in effective association across departments and better decision making processes.The software offers easy, cross-location teamwork and interaction amongst project members and investors in a central web-based project management system.
1
The Global COVID-19 Impact on Critical Care Device Market size is expected to reach USD 27.29 billion by 2021 from an estimated value of USD 37.97 billion in 2020.The critical care devices market is expected to witness a growth of 44.1% from 2019 to 2020.The market for critical care devices is driven primarily by the increasing number of ICU beds owing to the continuously rising COVID-19 cases, increasing demand for ventilators for effective management of critical COVID-19 patients, and ease of regulatory requirements to facilitate the production of critical care devices.Recent DevelopmentsOn 29th April 2020, Medtronic has ramped up the production of its high-performance ventilators by more than 40%.In addition, the company is working with third-parties to explore other non-traditional mechanisms to increase the production of ventilators, including providing its intellectual property and ventilator designs to the public for third-party ventilator productionGetinge has seen an increased global demand for advanced ventilators, extracorporeal life support (ECLS) equipment, and advanced monitoring for intensive care units since the outbreak of the COVID-19 pandemic.To meet the global demand, Getinge will temporarily increase its production of advanced ICU-ventilators by 160% in 2020, to 26,000 ventilators in total.In 2019, Getinge produced approximately 10,000 advanced ICU-ventilators at its production site in Solna, Sweden.Browse 85 market data Tables and 24 Figures spread through 90 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=216430576Market Segmentation in Depth: Based on products, the critical care devices market is segmented into ventilators & supplies, sleep apnea devices, patient monitors, hyperbaric oxygen therapy devices, infusion pumps, defibrillators, anesthesia machines, blood warmers, and other critical care devices supplies.The ventilators segment is expected to grow at the highest rate during the forecast period.
1
According to the new market research report “Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) – Global Forecast” published by MarketsandMarkets™.The Global Lymphedema Diagnostics Market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%.Major Market Growth Drivers:Growing Global Prevalence of LymphedemaGrowing Global Prevalence of CancerTechnological Advancements and Adoption of Newer Diagnostic ModalitiesIncreasing Investments, Funds, and Grants By Public-Private OrganizationsBrowse 107 market data Tables and 30 Figures spread through 165 Pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145177203The lymphoscintigraphy segment accounted for the largest share of the market.Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging.In 2018, the lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market.The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.The cancer segment accounted for the largest share of the lymphedema diagnostics market.On the basis of disease type, the market is segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis).The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018.The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.Key Questions Addressed by the Report:What are the growth opportunities related to the adoption of lymphedema diagnostics across major regions in the future?Emerging countries have immense opportunities for the growth and adoption of near-infrared fluorescence imaging for lymphedema diagnostics.Will this scenario continue in the next five years?Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145177203The lymphedema diagnostics therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World.
1
According MarketsandMarkets Research – The Molecular Cytogenetics Market is projected to reach USD 2.52 Billion, at a CAGR of 10.1%.Top-down and bottom-up approaches were used to estimate and validate the size of the global molecular cytogenetics market and to estimate the size of various other dependent sub markets.The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation—by products and region) through percentage splits from secondary and primary research.Market Growth DriversIncreasing Incidence of Genetic Disorders and CancerGrowing Focus on Targeted Cancer TreatmentIncreasing Aging Population and Subsequent Rise in Prevalence of Chronic DiseasesIncreasing Penetration of Molecular Cytogenetics in Clinical Pathological TestingBrowse 78 market data tables and 47 figures spread through 147 pages and in-depth TOC | Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=148469224                                                                   Molecular Cytogenetics MarketMarket Segmentation in Detailed:On the basis of techniques, the  market is segmented into comparative genomic hybridization, fluorescence in situ hybridization, in situ hybridization, and other techniques.Based on applications, the molecular cytogenetics market is segmented into genetic disorders, cancer, personalized medicine, and other applications.The genetic disorders segment is expected to account for the largest share of the global market.Based on end users, is segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others.The clinical and research laboratories segment is expected to account for the largest share of the global molecular cytogenetics market.Rise in healthcare expenditure has resulted in the increasing diagnosis of genetic disorder and cancer resulting in increasing use of cytogenetic kits and reagents in the above mentioned end users.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148469224Geographical Regions Mapped in Report:The global molecular cytogenetics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).North America is expected to account for the largest share of the market during the forecast period.
2
The best e-Commerce platform is a comprehensive software tool that allows merchants to build and manage a digital storefront for their products or services.Because best e-Commerce platforms create a centralized, digital hub for product and customer data, they allow eCommerce businesses to do things like customizing product information, manage web content and layout, allow online transactions to occur, and adjust the platform according to businesses’ online needs.360Quadrants, the most granular comparison platform, has released a quadrant on Best E-Commerce Platforms to help businesses make quicker and more informed decisions.Quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the E-Commerce Platforms space.360Quadrants conducts an in-depth SWOT analysis and accurately analyzes the companies considered for evaluation.This helps service providers in learning about new opportunities and areas where they lag behind their peers.It also helps clients in choosing the most appropriate vendor for their requirements.e-Commerce Platform: Drivers and LimitationsThe international e-Commerce platform market is driven by the software that is user-friendly and also inexpensive for small scale businesses.
1
360Quadrants has analyzed the companies offering the best Human Resource Software.This analysis will help businesses select the software that best suits their requirements.The analysis has been based on critical parameters taken from the company’s product offerings and business strategies.360Quadrants also helps businesses by providing critical insights derived from conducting a SWOT analysis.Competitive Leadership Mapping Terminology:Vendor evaluations are based on two broad categories: product offering and business strategy.Each category carries various criteria, based on which vendors have been evaluated.The evaluation criteria considered under product offerings include the breadth of offering, delivery (based on industries that the vendors cater to, deployment models, and subscriptions), features/functionality, delivery, product quality and reliability, and product differentiation.
1
360Quadrants has released a quadrant on best project management software to help businesses make quicker and more informed decisions.Ranking quadrants are generated post analysis of companies (product portfolios and business strategies) and will be updated every three months based on market and regional analyses and developments in the project management industry.Competitive Leadership Mapping Terminology:The competitive leadership mapping showcased provides information for Project Management Solution.The evaluation criteria considered under product offerings include the breadth of offering, delivery (based on industries that the vendors cater to, deployment models, and subscriptions), features/functionality, delivery, product quality and reliability, and product differentiation.The evaluation criteria considered under business strategy include geographic footprint (on the basis of geographic presence), channel strategy and fit, vision alignment, and effectiveness of growth (on the basis of innovations, partnerships, collaborations, and acquisitions).Read a Press Release on “Project Management Software”:https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-project-management-software-providersWhat are the major applications of Project Management Software?In Automobile Industry-Project Management Software Solutions in the Automotive Industry help in effective association across departments and better decision making processes.The software offers easy, cross-location teamwork and interaction amongst project members and investors in a central web-based project management system.
1
Accounting Software is computer software especially designed for accounting professionals to manage accounts and perform day to day accounting operations.With the instinctive mobile app, it enables sending invoices, track expenses, and connect with customers, all from the convenience of using mobile phones or tablets.This helps in getting all the information required within the stipulated time period for taxation purposes.Potential Issues of Accounting System;Developing industry-specific financial models: If you are facing a choice between a basic, standardized accounting solution and one created to match the industry's particular needs, go for the latter.However, in several situations, you are not going to be dependent on years of credibility to support its efficiency, so make sure that all the functionalities you need are there and do so beforehand.Scalability and customization: Since accounting interacts with a non-creative matter, few developers can do to make the digitized process more engaging than normal.But the best accounting software isn't going to be the most fun and open-to-configuration features you can get your hands on.What might be a successful plan of action on your part is to pick a flexible approach to make sure that the rules to company standards will be applied within.
1
According to the new market research report “Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the Therapeutic Drug Monitoring Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443The TDM Market growth is largely driven by factors such as the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R related to TDM, and technological advancements in immunoassay instruments.Increasing adoption in the treatment of autoimmune diseases is expected to provide a wide range of growth opportunities for players in the market.Consumables is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of product, the market is segmented into equipment and consumables.In 2019, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.Browse in-depth TOC on “Therapeutic Drug Monitoring Market“288 – Tables35 – Figures241 – PagesImmunoassays is expected to hold the largest share of the market in 2020Based on technology, the TDM Market is segmented into immunoassays and chromatography-MS.In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs.During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.Hospital laboratories segment commanded the largest share of the TDM Market in 2019By end user, the market is segmented into hospital laboratories, commercial & private laboratories, and other end users.Hospital laboratories accounted for the largest share of the market in 2019.
1
Accounting Software is computer software especially designed for accounting professionals to manage accounts and perform day to day accounting operations.A business organization requires accounting software in their day-to-day accounting practices for various purposes including internal and external audits, reports, and financial analysis to comply with legal or internal managerial requirements.With the instinctive mobile app, it enables sending invoices, track expenses, and connect with customers, all from the convenience of using mobile phones or tablets.This helps in getting all the information required within the stipulated time period for taxation purposes.Potential Issues of Accounting System;Developing industry-specific financial models: If you are facing a choice between a basic, standardized accounting solution and one created to match the industry's particular needs, go for the latter.However, in several situations, you are not going to be dependent on years of credibility to support its efficiency, so make sure that all the functionalities you need are there and do so beforehand.Scalability and customization: Since accounting interacts with a non-creative matter, few developers can do to make the digitized process more engaging than normal.But the best accounting software isn't going to be the most fun and open-to-configuration features you can get your hands on.
2
More

Top